Research

TYPE 2 ONSET DIABETES CAN BE AN EARLY WARNING SIGN OF PANCREATIC CANCER
January 29, 2017
Source: European Cancer Organization
Edited For Style, Length, and Insight
NOTE:
The following study was performed by researchers from the Prevention Research Institute in Lyon, France and was presented at the European Cancer Congress held in Amsterdam, Belgium. According to the PubMed Department of the US National Library of Medicine which reviewed this study, It is important to note that it analyzes these findings in context that Diabetes has...

Founded in 1999, the Pancreatic Cancer Action Network is the global leader in the fight against pancreatic cancer with a bold and comprehensive approach to Wage Hope through research, patient services, advocacy and community action. Our urgent mission is to improve outcomes for patients battling the disease today and double patient survival by 2020.
Why We Wage Hope
Pancreatic cancer kills more Americans than breast cancer and has a five-year survival of just 9 percent.1 The disease is the third leading...

TGen Overview
The Translational Genomics Research Institute (TGen) is a non-profit 501(c)(3) organization focused on developing earlier diagnostics and smarter treatments.
Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project and applying them to the development of diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases.
For the first time in history, we now have the knowledge to unravel the genetic components of common and complex diseases. The increased understanding of...